An improved method for the determination of fluticasone propionate in human plasma.
暂无分享,去创建一个
J. Oxford | A. Barrow | L. Laugher | T. Noctor | T. Phillips
[1] A. Bye,et al. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. , 2003, British journal of clinical pharmacology.
[2] B. Meibohm,et al. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. , 1998, The Journal of allergy and clinical immunology.
[3] M. Johnson. Development of fluticasone propionate and comparison with other inhaled corticosteroids. , 1998, The Journal of allergy and clinical immunology.
[4] B. Meibohm,et al. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration , 1998, European Journal of Clinical Pharmacology.
[5] K. Brown,et al. A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry. , 1997, Journal of pharmaceutical and biomedical analysis.
[6] G. Harrison,et al. A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. , 1993, Journal of pharmaceutical and biomedical analysis.